Literature DB >> 19135092

Validation of a novel social investigation task that may dissociate social motivation from exploratory activity.

Terrence Deak1, Hiroyuki Arakawa, Marni Y V Bekkedal, Jaak Panksepp.   

Abstract

The present series of studies provide validation of a new paradigm that uniquely combines the assessment of the propensity to engage in social investigation with measures of (nonsocial) exploratory activity in rats. Assessment of this social investigation paradigm indicated that (a) rats showed a robust preference for social investigation over nonsocial exploratory activity, (b) female rats showed a greater preference for social investigation than male rats, (c) no signs of habituation in these responses were observed when rats were tested once daily for 4 consecutive days, (d) the preference for social investigation was stable and robust in both the dark and light periods of the daily light cycle for 5 consecutive days, and (e) testing under bright light conditions suppressed social investigation. In addition, acute administration of opiate drugs, low dose morphine (1.0 mg/kg) and naltrexone (1.0 mg/kg) produced a more robust attenuation of social investigation than nonsocial exploratory activity. Amphetamine increased both forms of investigation and haloperidol had the opposite effect, but the overall preference for social investigation over exploratory activity remained largely intact after both amphetamine and haloperidol injection. Together, these findings validate the use of this behavioral task to assess changes in social-motivation and general exploratory activity. Importantly, the task is bi-directionally sensitive to subject characteristics (i.e., sex), drug manipulations which modulate social motivation, and environmental manipulations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19135092      PMCID: PMC2678686          DOI: 10.1016/j.bbr.2008.12.011

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  45 in total

Review 1.  Social isolation stress and neuroactive steroids.

Authors:  M Serra; E Sanna; M C Mostallino; G Biggio
Journal:  Eur Neuropsychopharmacol       Date:  2006-04-19       Impact factor: 4.600

2.  Colony formation of C57BL/6J mice in visible burrow system: identification of eusocial behaviors in a background strain for genetic animal models of autism.

Authors:  Hiroyuki Arakawa; D Caroline Blanchard; Robert J Blanchard
Journal:  Behav Brain Res       Date:  2006-09-12       Impact factor: 3.332

3.  Social play alters regional brain opioid receptor binding in juvenile rats.

Authors:  L J Vanderschuren; E A Stein; V M Wiegant; J M Van Ree
Journal:  Brain Res       Date:  1995-05-22       Impact factor: 3.252

4.  Fetal and neonatal exposure to trimethylolpropane phosphate alters rat social behavior and emotional responsivity.

Authors:  M Y Bekkedal; J Rossi; J Panksepp
Journal:  Neurotoxicol Teratol       Date:  1999 Jul-Aug       Impact factor: 3.763

5.  Protracted increases in core body temperature and interleukin-1 following acute administration of lipopolysaccharide: implications for the stress response.

Authors:  Terrence Deak; Cherie Bellamy; Kelly A Bordner
Journal:  Physiol Behav       Date:  2005-06-30

6.  Morphine attenuates the effects of juvenile isolation in rats.

Authors:  C L Van den Berg; J M Van Ree; B M Spruijt
Journal:  Neuropharmacology       Date:  2000-04-03       Impact factor: 5.250

7.  The serotonin 5-HT(2A) receptor subtype does not mediate apomorphine-induced aggressive behaviour in male Wistar rats.

Authors:  T Skrebuhhova-Malmros; K Pruus; R Rudissaar; L Allikmets; V Matto
Journal:  Pharmacol Biochem Behav       Date:  2000-10       Impact factor: 3.533

8.  Effects of juvenile isolation and morphine treatment on social interactions and opioid receptors in adult rats: behavioural and autoradiographic studies.

Authors:  C L Van den Berg; J M Van Ree; B M Spruijt; I Kitchen
Journal:  Eur J Neurosci       Date:  1999-09       Impact factor: 3.386

9.  Fear, risk assessment, and playfulness in the juvenile rat.

Authors:  Stephen M Siviy; Kelly A Harrison; Iain S McGregor
Journal:  Behav Neurosci       Date:  2006-02       Impact factor: 1.912

10.  Long-term changes in rat social behavior following treatment with trimethylolpropane.

Authors:  M Y Bekkedal; J Panksepp; J Rossi
Journal:  Neurotoxicol Teratol       Date:  1998 May-Jun       Impact factor: 3.763

View more
  5 in total

1.  Limited physical contact through a mesh barrier is sufficient for social reward-conditioned place preference in adolescent male rats.

Authors:  Natalie A Peartree; Lauren E Hood; Kenneth J Thiel; Federico Sanabria; Nathan S Pentkowski; Kayla N Chandler; Janet L Neisewander
Journal:  Physiol Behav       Date:  2011-10-08

2.  Enhancement of the hypothalamic-pituitary-adrenal axis but not cytokine responses to stress challenges imposed during withdrawal from acute alcohol exposure in Sprague-Dawley rats.

Authors:  Hollin M Buck; Cara M Hueston; Christopher Bishop; Terrence Deak
Journal:  Psychopharmacology (Berl)       Date:  2011-07-07       Impact factor: 4.530

3.  Acute illness-induced behavioral alterations are similar to those observed during withdrawal from acute alcohol exposure.

Authors:  Laura Richey; Tamara L Doremus-Fitzwater; Hollin M Buck; Terrence Deak
Journal:  Pharmacol Biochem Behav       Date:  2012-08-17       Impact factor: 3.533

4.  Central infusion of interleukin-1 receptor antagonist blocks the reduction in social behavior produced by prior stressor exposure.

Authors:  Hiroyuki Arakawa; Peter Blandino; Terrence Deak
Journal:  Physiol Behav       Date:  2009-05-03

5.  Low-dose lipopolysaccharide (LPS) inhibits aggressive and augments depressive behaviours in a chronic mild stress model in mice.

Authors:  Yvonne Couch; Alexander Trofimov; Natalyia Markova; Vladimir Nikolenko; Harry W Steinbusch; Vladimir Chekhonin; Careen Schroeter; Klaus-Peter Lesch; Daniel C Anthony; Tatyana Strekalova
Journal:  J Neuroinflammation       Date:  2016-05-16       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.